Literature DB >> 24709120

RNA-protein interactions in unstable microsatellite diseases.

Apoorva Mohan1, Marianne Goodwin1, Maurice S Swanson2.   

Abstract

A novel RNA-mediated disease mechanism has emerged from studies on dominantly inherited neurological disorders caused by unstable microsatellite expansions in non-coding regions of the genome. These non-coding tandem repeat expansions trigger the production of unusual RNAs that gain a toxic function, which involves the formation of RNA repeat structures that interact with, and alter the activities of, various factors required for normal RNA processing as well as additional cellular functions. In this review, we explore the deleterious effects of toxic RNA expression and discuss the various model systems currently available for studying RNA gain-of-function in neurologic diseases. Common themes, including bidirectional transcription and repeat-associated non-ATG (RAN) translation, have recently emerged from expansion disease studies. These and other discoveries have highlighted the need for further investigations designed to provide the additional mechanistic insights essential for future therapeutic development.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bidirectional transcription; Microsatellite; Neurologic disease; Protein sequestration; RNA foci; RNA-mediated toxicity

Mesh:

Substances:

Year:  2014        PMID: 24709120      PMCID: PMC4174988          DOI: 10.1016/j.brainres.2014.03.039

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  137 in total

Review 1.  Mechanisms of RNA-mediated disease.

Authors:  Jason R O'Rourke; Maurice S Swanson
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

2.  Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.

Authors:  Clotilde Lagier-Tourenne; Michael Baughn; Frank Rigo; Shuying Sun; Patrick Liu; Hai-Ri Li; Jie Jiang; Andrew T Watt; Seung Chun; Melanie Katz; Jinsong Qiu; Ying Sun; Shuo-Chien Ling; Qiang Zhu; Magdalini Polymenidou; Kevin Drenner; Jonathan W Artates; Melissa McAlonis-Downes; Sebastian Markmiller; Kasey R Hutt; Donald P Pizzo; Janet Cady; Matthew B Harms; Robert H Baloh; Scott R Vandenberg; Gene W Yeo; Xiang-Dong Fu; C Frank Bennett; Don W Cleveland; John Ravits
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

3.  Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Jihae Shin; Yuan Yuan; Stuart G Beattie; Thurman M Wheeler; Charles A Thornton; Maurice S Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

4.  Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis.

Authors:  Laura Kennedy; Elizabeth Evans; Chiung-Mei Chen; Lyndsey Craven; Peter J Detloff; Margaret Ennis; Peggy F Shelbourne
Journal:  Hum Mol Genet       Date:  2003-10-21       Impact factor: 6.150

5.  Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration.

Authors:  Zihui Xu; Mickael Poidevin; Xuekun Li; Yujing Li; Liqi Shu; David L Nelson; He Li; Chadwick M Hales; Marla Gearing; Thomas S Wingo; Peng Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-03       Impact factor: 11.205

6.  Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.

Authors:  Peng Jin; Ranhui Duan; Abrar Qurashi; Yunlong Qin; Donghua Tian; Tracie C Rosser; Huijie Liu; Yue Feng; Stephen T Warren
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

7.  Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities.

Authors:  M S Swanson; G Dreyfuss
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

8.  New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats.

Authors:  François-Xavier Laurent; Alain Sureau; Arnaud F Klein; François Trouslard; Erwan Gasnier; Denis Furling; Joëlle Marie
Journal:  Nucleic Acids Res       Date:  2011-12-09       Impact factor: 16.971

Review 9.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

10.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.

Authors:  K L Taneja; M McCurrach; M Schalling; D Housman; R H Singer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  26 in total

1.  ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.

Authors:  Stephen Moore; Eric Alsop; Ileana Lorenzini; Alexander Starr; Benjamin E Rabichow; Emily Mendez; Jennifer L Levy; Camelia Burciu; Rebecca Reiman; Jeannie Chew; Veronique V Belzil; Dennis W Dickson; Janice Robertson; Kim A Staats; Justin K Ichida; Leonard Petrucelli; Kendall Van Keuren-Jensen; Rita Sattler
Journal:  Acta Neuropathol       Date:  2019-04-03       Impact factor: 17.088

Review 2.  Modeling simple repeat expansion diseases with iPSC technology.

Authors:  Edyta Jaworska; Emilia Kozlowska; Pawel M Switonski; Wlodzimierz J Krzyzosiak
Journal:  Cell Mol Life Sci       Date:  2016-06-03       Impact factor: 9.261

Review 3.  Protein sequestration as a normal function of long noncoding RNAs and a pathogenic mechanism of RNAs containing nucleotide repeat expansions.

Authors:  Ginny R Morriss; Thomas A Cooper
Journal:  Hum Genet       Date:  2017-05-08       Impact factor: 4.132

4.  Actinomycin D Specifically Reduces Expanded CUG Repeat RNA in Myotonic Dystrophy Models.

Authors:  Ruth B Siboni; Masayuki Nakamori; Stacey D Wagner; Adam J Struck; Leslie A Coonrod; Shanee A Harriott; Daniel M Cass; Matthew K Tanner; J Andrew Berglund
Journal:  Cell Rep       Date:  2015-12-10       Impact factor: 9.423

5.  Repeat-Associated Non-ATG Translation: Molecular Mechanisms and Contribution to Neurological Disease.

Authors:  Lien Nguyen; John Douglas Cleary; Laura P W Ranum
Journal:  Annu Rev Neurosci       Date:  2019-03-25       Impact factor: 12.449

6.  MBNL Sequestration by Toxic RNAs and RNA Misprocessing in the Myotonic Dystrophy Brain.

Authors:  Marianne Goodwin; Apoorva Mohan; Ranjan Batra; Kuang-Yung Lee; Konstantinos Charizanis; Francisco José Fernández Gómez; Sabiha Eddarkaoui; Nicolas Sergeant; Luc Buée; Takashi Kimura; H Brent Clark; Joline Dalton; Kenji Takamura; Sebastien M Weyn-Vanhentenryck; Chaolin Zhang; Tammy Reid; Laura P W Ranum; John W Day; Maurice S Swanson
Journal:  Cell Rep       Date:  2015-08-06       Impact factor: 9.423

Review 7.  RNA-binding proteins implicated in neurodegenerative diseases.

Authors:  Mark R Cookson
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-09-23       Impact factor: 9.957

Review 8.  RAN translation-What makes it run?

Authors:  Katelyn M Green; Alexander E Linsalata; Peter K Todd
Journal:  Brain Res       Date:  2016-04-06       Impact factor: 3.252

9.  Differential Toxicity of Nuclear RNA Foci versus Dipeptide Repeat Proteins in a Drosophila Model of C9ORF72 FTD/ALS.

Authors:  Helene Tran; Sandra Almeida; Jill Moore; Tania F Gendron; UmaDevi Chalasani; Yubing Lu; Xing Du; Jeffrey A Nickerson; Leonard Petrucelli; Zhiping Weng; Fen-Biao Gao
Journal:  Neuron       Date:  2015-09-23       Impact factor: 17.173

10.  Selection pressure on human STR loci and its relevance in repeat expansion disease.

Authors:  Makoto K Shimada; Ryoko Sanbonmatsu; Yumi Yamaguchi-Kabata; Chisato Yamasaki; Yoshiyuki Suzuki; Ranajit Chakraborty; Takashi Gojobori; Tadashi Imanishi
Journal:  Mol Genet Genomics       Date:  2016-06-11       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.